Cabaletta Bio, Inc. (CABA) Ownership

$2.44

south_east
-$0.09 (-3.56%)
Day's range
$2.37
Day's range
$2.59

Cabaletta Bio, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 11/14/2025 9.68 M $22.64 M   0.00% 9.46%
ADAGE CAPITAL PARTNERS GP, L.L.C. 11/14/2025 8.83 M $20.66 M   0.00% 8.63%
JENNISON ASSOCIATES LLC 10/30/2025 8.50 M $19.88 M   41.15% 8.31%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 11/14/2025 8.36 M $19.57 M   23.09% 8.18%
CORMORANT ASSET MANAGEMENT, LP 11/14/2025 5.00 M $11.70 M   0.00% 4.89%
VANGUARD GROUP INC 11/07/2025 4.19 M $9.81 M   21.45% 4.10%
WOODLINE PARTNERS LP 11/14/2025 2.14 M $5.00 M   75.25% 2.09%
HEIGHTS CAPITAL MANAGEMENT, INC 11/18/2025 2.08 M $4.88 M   -33.71% 2.04%
BLACKROCK, INC. 11/12/2025 1.62 M $3.79 M   67.00% 1.59%
SUPERSTRING CAPITAL MANAGEMENT LP 11/14/2025 1.54 M $3.61 M   45.61% 1.51%
MORGAN STANLEY 11/14/2025 1.47 M $3.45 M   11.31% 1.44%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 1.34 M $3.13 M   962.19% 1.31%
MARSHALL WACE, LLP 11/13/2025 1.33 M $3.10 M   594.42% 1.30%
ALYESKA INVESTMENT GROUP, L.P. 11/17/2025 1.30 M $3.04 M   -72.92% 1.27%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2025 1.29 M $3.03 M   -40.79% 1.27%
SCHONFELD STRATEGIC ADVISORS LLC 11/14/2025 1.04 M $2.44 M   -29.68% 1.02%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 920.34 K $2.15 M   66.29% 0.90%
JPMORGAN CHASE & CO 11/26/2025 537.65 K $1.26 M   565.44% 0.87%
OPALEYE MANAGEMENT INC. 11/14/2025 808.88 K $1.89 M   100.00% 0.79%
CITADEL ADVISORS LLC 11/14/2025 705.47 K $1.65 M   -58.21% 0.69%
BURKEHILL GLOBAL MANAGEMENT, LP 11/14/2025 700.00 K $1.64 M   -63.16% 0.68%
MILLENNIUM MANAGEMENT LLC 11/14/2025 686.81 K $1.61 M   -19.70% 0.67%
TWO SIGMA INVESTMENTS, LP 11/14/2025 470.48 K $1.10 M   86.43% 0.46%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 417.10 K $976.01 K   66.84% 0.41%
UBS GROUP AG 11/13/2025 405.12 K $947.98 K   -14.18% 0.40%
ALMITAS CAPITAL LLC 11/17/2025 387.49 K $906.73 K   5.44% 0.38%
STATE STREET CORP 11/14/2025 376.80 K $881.71 K   72.87% 0.37%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 372.11 K $870.73 K   201.00% 0.36%
RAIFFEISEN BANK INTERNATIONAL AG 11/10/2025 350.00 K $833.00 K   16.67% 0.34%
TWO SIGMA ADVISERS, LP 11/14/2025 331.00 K $774.54 K   -19.97% 0.32%
XTX TOPCO LTD 11/14/2025 284.30 K $665.26 K   192.31% 0.28%
GOLDMAN SACHS GROUP INC 11/14/2025 272.60 K $637.87 K   -22.84% 0.27%
BANK OF AMERICA CORP /DE/ 11/14/2025 268.06 K $627.26 K   -46.20% 0.26%
CAPTION MANAGEMENT, LLC 11/14/2025 250.00 K $585.00 K   100.00% 0.24%
CITADEL ADVISORS LLC 11/14/2025 244.80 K $572.83 K   220.00% 0.24%
NORTHERN TRUST CORP 11/14/2025 226.99 K $531.15 K   70.64% 0.22%
JANE STREET GROUP, LLC 11/14/2025 190.20 K $445.07 K   139.85% 0.19%
ACADIAN ASSET MANAGEMENT LLC 11/13/2025 186.52 K $433.00 K   1,131.89% 0.18%
INVESCO LTD. 11/13/2025 122.80 K $287.35 K   44.76% 0.12%
FEDERATED HERMES, INC. 11/03/2025 112.03 K $262.15 K   -67.48% 0.11%
JANE STREET GROUP, LLC 11/14/2025 104.66 K $244.91 K   -56.08% 0.10%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/14/2025 95.68 K $223.88 K   109.47% 0.09%
ROYAL BANK OF CANADA 11/14/2025 91.72 K $214.00 K   100.00% 0.09%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2025 89.16 K $208.63 K   100.00% 0.09%
TD ASSET MANAGEMENT INC 11/10/2025 88.60 K $207.32 K   0.00% 0.09%
FRED ALGER MANAGEMENT, LLC 11/14/2025 59.81 K $139.96 K   0.00% 0.06%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 50.82 K $118.93 K   0.40% 0.05%
BANK OF NEW YORK MELLON CORP 11/03/2025 47.81 K $111.88 K   0.00% 0.05%
JEFFERIES FINANCIAL GROUP INC. 11/13/2025 47.50 K $111.15 K   -97.62% 0.05%
QUADRATURE CAPITAL LTD 11/13/2025 42.91 K $100.41 K   100.00% 0.04%

Cabaletta Bio, Inc. institutional Ownership - FAQ's

During the previous two years, 108 institutional investors and hedge funds held shares of Cabaletta Bio, Inc.. The most heavily invested institutionals were:

Bain Capital Life Sciences Investors, LLC: 9.68 M

ADAGE CAPITAL PARTNERS GP, L.L.C.: 8.83 M

JENNISON ASSOCIATES LLC: 8.5 M

T. Rowe Price Investment Management, Inc.: 8.36 M

Cormorant Asset Management, LP: 5 M

VANGUARD GROUP INC: 4.19 M

67.68% of Cabaletta Bio, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 74.50 M shares in the last 24 months. This purchase volume represents approximately $181.78 M in transactions.